Top 50 Medical Device Startup Investors in Oceania (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Brandon Capital
VC Fund
|
8 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$120M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
6 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.3M–$16M |
|
Artesian VC
VC Fund
|
6 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Icehouse Ventures
VC Fund
|
5 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $593k–$16M |
|
Breakthrough Victoria
VC Fund
|
4 | Australia, United States, Philippines | Seed, Series A | Health Care, Manufacturing, Biotechnology | $708k–$36M |
|
Melbourne Angels
VC Fund
|
4 | Australia, United States, New Zealand | Angel, Seed | Biotechnology, Information Technology, Internet | $34k–$1.3M |
|
Pacific Channel
VC Fund
|
4 | New Zealand, Australia | Seed, Series A, Pre-Seed | Medical Device, Medical, CleanTech | $1.1M–$5M |
|
New Zealand Growth Capital Partners
VC Fund
|
4 | New Zealand, United States | Seed, Series A | Software, Medical Device, SaaS | $830k–$17M |
|
Sydney Angels
VC Fund
|
4 | Australia, United States | Seed, Angel, Series A | Software, SaaS, Health Care | $120k–$4.8M |
|
Global from Day One
VC Fund
|
4 | New Zealand, United States, China | Seed, Series A | Software, SaaS, Video | $612k–$5M |
|
Uniservices
VC Fund
|
3 | New Zealand | Seed, Pre-Seed | Medical Device, SaaS, Audio | |
|
Uniseed
VC Fund
|
3 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $404k–$22M |
|
Cure Kids Ventures
VC Fund
|
3 | New Zealand | Seed, Pre-Seed, Series A | Medical Device, SaaS, Medical | |
|
Significant Ventures
VC Fund
|
3 | Australia | Seed, Series A | Manufacturing, Software, Health Care | $67k–$8.2M |
|
K1W1
VC Fund
|
3 | New Zealand, United States | Seed, Series A | Software, SaaS, Biotechnology | $419k–$17M |
|
IP Group
VC Fund
|
3 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$23M |
|
Punakaiki Fund
VC Fund
|
2 | New Zealand, United States | Seed, Series B | Software, SaaS, Information Technology | $355k–$14M |
|
Enterprise Angels
VC Fund
|
2 | New Zealand, United States, United Kingdom | Seed, Angel | Software, Health Care, Information Technology | $153k–$2.4M |
|
Allan Moss
Angel
|
2 | Australia, United States, The Netherlands | Series A, Seed | Health Care, Medical Device, Biotechnology | $2.4M–$8.8M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B | Software, Financial Services, FinTech | $1.7M–$26M |
|
Flying Kiwis
VC Fund
|
2 | New Zealand | Seed | SaaS, 3D Technology, Medical Device | $5M–$5M |
|
GD1 (Global From Day One)
VC Fund
|
2 | New Zealand, United States, China | Seed, Series A, Pre-Seed | Software, Information Technology, SaaS | $500k–$15M |
|
Brisbane Angels
VC Fund
|
2 | Australia, United States, New Zealand | Seed, Angel, Pre-Seed | Software, Biotechnology, Machine Learning | $120k–$1.3M |
|
Global Health Investment Fund (GHIF)
VC Fund
|
2 | United States, India, Austria | Series B, Series C | Health Care, Biotechnology, Medical Device | $4.5M–$18M |
|
Matū Group
VC Fund
|
2 | New Zealand, United States | Seed | Biotechnology, Robotics, Nanotechnology | |
|
Uniseed Ventures
VC Fund
|
2 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
Movac
VC Fund
|
2 | New Zealand, United States, Australia | Seed, Series A | Software, SaaS, E-Commerce | $795k–$16M |
|
SOSV
VC Fund
|
1 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Playford Capital
VC Fund
|
1 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
Terra Rossa Capital
VC Fund
|
1 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | |
|
Right Click Capital
VC Fund
|
1 | Australia, Singapore, United States | Seed, Series A | Software, SaaS, Information Technology | $200k–$16M |
|
Victoria University of Wellington
VC Fund
|
1 | Australia | Seed | Health Care, Biotechnology, Medical Device | |
|
Artesian Investment
Angel
|
1 | United States, India, Australia | Pre-Seed, Seed, Series A | Artificial Intelligence, Agriculture, Information Technology | |
|
Bridgewest Group
VC Fund
|
1 | New Zealand, United States | Seed | Mobile, Hardware, Internet | |
|
UniSA Ventures
VC Fund
|
1 | Australia | Seed | Software, Health Care, Biotechnology | |
|
Flying Kiwi Angels
VC Fund
|
1 | New Zealand, United States | Seed, Angel, Pre-Seed | Software, Information Technology, Apps | $473k–$1.3M |
|
Hostplus
VC Fund
|
1 | Australia, United Kingdom, United States | Series A, Series B, Series C | Software, Biotechnology, Renewable Energy | |
|
Josh Hannah
Angel
|
1 | United States, Singapore, Norway | Series A, Seed, Series B | Software, Information Technology, Internet | |
|
CoAct Capital
VC Fund
|
1 | Australia | Series A | Advice, Hospital, Software | |
|
LCO Capital
VC Fund
|
1 | New Zealand | Health Care, Manufacturing, Medical Device | ||
|
Archangel Ventures
VC Fund
|
1 | Australia, United States, Philippines | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | |
|
SFC Capital
VC Fund
|
1 | United Kingdom, United States, Canada | Pre-Seed, Seed | Software, Artificial Intelligence, Information Technology | |
|
Topcon Healthcare
VC Fund
|
1 | New Zealand | Series A | Health Care, Medical Device, Health Diagnostics | |
|
Grand Challenges Canada
VC Fund
|
1 | Canada, United States, Australia | Grant, Seed, Debt Financing | Health Care, Medical Device, Biotechnology | |
|
Sante Ventures
VC Fund
|
1 | United States, Canada, Australia | Series A, Series B, Series C | Health Care, Medical, Biotechnology | |
|
PsyMed Ventures
VC Fund
|
1 | United States, Canada, Israel | Seed, Series A | Health Care, Biotechnology, Medical | |
|
Development Bank of Wales
VC Fund
|
1 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Biotechnology | |
|
Dexcom Ventures
VC Fund
|
1 | Australia | Sensor, Medical, Wearables | ||
|
VU Venture Partners
VC Fund
|
1 | United States, Colombia, India | Seed, Series A | Software, Health Care, Machine Learning | |
|
Powerhouse Ventures
VC Fund
|
1 | United States, Australia, United Kingdom | Seed, Series A, Pre-Seed | Software, Energy, Solar | |
| Access all 50 investors in Oceania Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 49
- Round size: Seed $673k–$6.7M; Series A $4.9M–$81M; Series B $5M–$120M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 25
- Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 223
- Round size: Seed $120k–$4M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Living Models — Living Models is concentrating on this field by employing AI methods on biological data, especially in plant science, where enhancing crop yield and resilience is becoming crucial as global agriculture is impacted by climatic challenges.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 169
- Round size: Seed $593k–$5M; Series A $2.2M–$16M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $69M in 2021
Portfolio highlights
- Appetise — MenuAid is a cheaper, flexible and more sustainable alternative to meal-kit delivery providers. We provide Kiwis with a weekly meal plan, complete with recipes and a list of ingredients that can either be self-shopped or collected/delivered from your favourite supermarkets.
- Caruso — AI-native fund administration for private markets. Trusted by 900+ real estate, private credit, and private equity funds to save time, impress investors, and grow AUM.
- Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 45
- Round size: Seed $708k–$7.1M; Series A $1.8M–$36M
- Lead/follow: 62% lead, 38% follow
Portfolio highlights
- DeepDerm — DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies.
- InnovaIVF — InnovaIVF transforms the reproductive technology landscape with innovative solutions.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Internet
- Stage:Angel, Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 40
- Round size: Seed $34k–$1.3M; Angel $219k–$918k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
- Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
Investing in great people solving hard problems to create a better future.
Show more...Investment focus
- Industry: Medical Device, Medical, CleanTech
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand, Australia
Investor stats
- Total investments: 14
- Round size: Seed $1.1M–$5M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- PHNXX — PHNXX provides containerised clean and reliable energy solutions for business operations.
- Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more...Investment focus
- Industry: Software, Medical Device, SaaS
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 25
- Round size: Seed $830k–$6.4M; Series A $6.2M–$17M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Angel, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 93
- Round size: Seed $120k–$1.3M; Angel $130k–$890k; Series A $250k–$4.8M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Okkular — Okkular is an AI based fashion tech startup.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, SaaS, Video
- Stage:Seed, Series A
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 29
- Round size: Seed $612k–$5M; Series A $1.2M–$3M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Auckland University's commercialisation arm
Show more...Investment focus
- Industry: Medical Device, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 5
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Acumino — Acumino offers next-generation, AI powered robot models for the execution of highly dexterous tasks in industrial automation settings. The Acumino AI is trained on the most accurate data of robot interactions and facilitates the deployment of next-generation intelligent robot workers in a fast, scalable, reliable, cost-efficient manner, unlockingunmatched dexterity & ROI.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $600k–$4.2M; Series A $1.6M–$16M; Series B $404k–$22M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap —
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to
Show more...Investment focus
- Industry: Medical Device, SaaS, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 5
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- chnnl — Optimise your employee wellbeing strategy with chnnl. Centralised resource management, track psychosocial risks and team psychological wellbeing measurement.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 25
- Round size: Seed $67k–$5M; Series A $4.5M–$8.2M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Wavewise Analytics — Cyban is a medical equipment manufacturing company that manufactures brain oxygen monitors.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Visionary Machines — Superior perception for next-generation autonomy
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 79
- Round size: Seed $437k–$3.5M; Series A $419k–$17M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Appetise — MenuAid is a cheaper, flexible and more sustainable alternative to meal-kit delivery providers. We provide Kiwis with a weekly meal plan, complete with recipes and a list of ingredients that can either be self-shopped or collected/delivered from your favourite supermarkets.
- Factor — Plug and play forecasting and pricing tools for modern energy utilities.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 188
- Round size: Seed $393k–$7.6M; Series A $2M–$23M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Lumai — Lumai delivers optical compute for the inference era, enabling up to 50x AI performance and 90% less power. Supports billion-parameter LLMs today.
- AudioScenic — THE NEW DIMENSION IN SOUND
- Intrinsic Semiconductor Technologies — Exciting new developments around the Internet of Things, Big Data, autonomous vehicles, and Artificial Intelligence highlight how our approach to computation must fundamentally change.
Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series B
- Geography: New Zealand, United States
Investor stats
- Total investments: 39
- Round size: Seed $355k–$5M; Series B $5.8M–$14M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Astute Access — Astute is using smart locks and cloud software, our enterprise solutions deliver a robust, scalable access control solution.
- Projectworks — Project Works is a cloud based workforce management platform designed to help professional & creative services businesses better manage their organisations in the areas of project management, project financials, and people management. Our mission is to provide a platform that enables world class services businesses to get the most out of theirexisting workforce, and enable them to grow.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Angel
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 105
- Round size: Seed $153k–$2.4M; Angel $229k–$651k
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $12M in 2019
Portfolio highlights
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- HealthNow — HealthNow provides accessible healthcare services that give you control of your health. Manage how you access care, when you need it.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series A, Seed
- Geography: Australia, United States, The Netherlands
Investor stats
- Total investments: 9
- Round size: Series A $2.4M–$8.8M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Convertible Note, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Series B $7M–$26M; Convertible Note $1.7M–$17M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- Carma — Want to sell or trade in your old car? Good news: Carma takes care of both! Get a valuation online, with easy drop-off and seamless transition between cars.
- Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
- Amaero International — Amaero International is a manufacturer of high-temperature powder metals and specialty powders. The company produces refractory, titanium, and specialty alloyed powders using gas atomization and hot isostatic pressing (HIP) technologies. Amaero International serves sectors including defense, aerospace, energy, and medical.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Super-seeded by new entry: Flying Kiwi Angels
Show more...Investment focus
- Industry: SaaS, 3D Technology, Medical Device
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 2
- Round size: Seed $5M–$5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 55
- Round size: Seed $500k–$7.3M; Pre-Seed $860k–$2.3M; Series A $1.2M–$15M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Orbica — Orbica develops innovative, cross-industry location data solutions, services and products.
- Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
- NextWork — Building the best online learning experience to switch careers and upskill. Join the waitlist today, we are waiting for you!
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 45
- Round size: Seed $120k–$1.3M; Angel $337k–$629k; Pre-Seed $200k–$1.3M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Tendl — Write tenders faster with Tendl's AI tool. Keep your data private and secure. Easy installation, no sharing. Boost productivity and streamline your contract opportunities.
- Shopfront — Automate multi-channel selling across eBay, Depop, Grailed & Shopify. AI-powered listings, bulk uploads, inventory sync.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series B, Series C
- Geography: United States, India, Austria
Investor stats
- Total investments: 18
- Round size: Series B $7.5M–$18M; Series C $4.5M–$14M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $108M in 2012
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Nanotechnology
- Stage:Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 8
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ligar — Revolutionising molecular extraction through nanotechnology (molecularly imprinted polymers)
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- PowerON — Dielectric Elastomers for Soft Robotics
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 41
- Round size: Seed $1.5M–$4.9M; Series A $795k–$16M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $125M in 2022
Portfolio highlights
- LawVu — Our all-in-one connected platform enables your legal team to manage all legal matters, contracts, spend and legal operations. Book your free demo now.
- Advemto — Advemto is the manufacturer and developer of ultrafast spectroscopy systems that help researchers.
- Re-Leased Software Company Limited — Commercial property management software that makes life easier for property managers, landlords and owners.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Right Click Capital - Australian Venture Capital Firm
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Australia, Singapore, United States
Investor stats
- Total investments: 61
- Round size: Seed $200k–$3.6M; Series A $3.3M–$16M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Artesian Investment
Show more...Investment focus
- Industry: Artificial Intelligence, Agriculture, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, India, Australia
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
- LYRO Robotics — A robotic packing solution for fruits and vegetables
- HUVIAiR Technologies — A full-stack construction management tool designed for executive leadership. Deliver projects faster, improve build quality and reduce project costs.
Bridgewest Group, private investment firm with global investments in innovative software, semiconductor, life sciences and biotech, and AI is empowering people for a better tomorrow.
Show more...Investment focus
- Industry: Mobile, Hardware, Internet
- Stage:Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Gimbal — The world's best brands and agencies rely on Infillion for advertising and software solutions that connect people, places, and digital experiences.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Flying Kiwi Angels ? Helping Kiwi Startups
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Angel, Pre-Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 15
- Round size: Seed $795k–$1.2M; Angel $592k–$918k; Pre-Seed $473k–$1.3M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
- Kara Technologies — Content accessibility using a signing avatar. Accessible solutions are at the core of all that we do here at Kara. One of our main goals is finding smarter ways of using technology that will help build a better future for everyone, in all areas of life.
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more...Investment focus
- Industry: Software, Biotechnology, Renewable Energy
- Stage:Series A, Series B, Series C
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 52
- Lead/follow: no public data
Portfolio highlights
- Airwallex — Grow your business faster with Airwallex - global business accounts, high speed transfers, multi-currency cards, online payments, embedded finance, and more.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
- Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Josh Hannah
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Series A, Seed, Series B
- Geography: United States, Singapore, Norway
Investor stats
- Total investments: 61
- Lead/follow: no public data
Portfolio highlights
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
- Monkey Tilt — Join your new crypto casino at Monkey Tilt. Play with crypto, earn points & win prizes. Tilt Club VIP program includes bonuses, merch drops & more.
- 1inch — Swap crypto & tokens at the best rates across 13+ chains. The 1inch swap aggregator is your gateway to secure and efficient DeFi.
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more...Investment focus
- Industry: Advice, Hospital, Software
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Knocknoc — Cybersecurity software company specialising in attack surface reduction technologies
- Vantari VR — Virtual Reality for Healthcare
- DASH Technology — DASH Technology provides financial services. They provide software, platform, and even wealth management space services. They provide advisers and broader wealth services. They provide inquiries through email, phone calls, and online applications.
LCO Capital offer value-add financial and intellectual capital to underperforming business lines, using an LCO℠ business model.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Medical Device
- Geography: New Zealand
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Chitogel — Chitogel is a medical device company that offers edge wound healing gel for use in endoscopic sinus surgery.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Archangel is an early stage venture capital fund based in Australia. We work with great founders and investors to build game changing companies together.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Termina — Termina operates as an energy tech startup.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 282
- Lead/follow: no public data
Portfolio highlights
- TILKI — TILKI is an AI-powered game creation platform that democratizes video game development by enabling all creators to build immersive games without coding.
- ZERØTEC — ZERØTEC is an pattern design and nesting software platform for fashion designers and manufacturers
- Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
Topcon Healthcare solutions provide imaging, diagnostic solutions, and intelligent data technology. They specialize in developing optical, sensing, and control solutions with digital transformation technologies for industries. Their solutions include multimodal imaging, vendor-neutral data management, and groundbreaking remote diagnostictechnology.
Show more...Investment focus
- Industry: Health Care, Medical Device, Health Diagnostics
- Stage:Series A
- Geography: New Zealand
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- RetiSpec — RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye.
- Toku Eyes — Instant Healthcare Diagnostics. Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics...
- Retinai — RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
Learn how we find, fund and support high-impact innovations
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Grant, Seed, Debt Financing
- Geography: Canada, United States, Australia
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- OmniVis — OmniVis is a technology company creating handheld devices to rapidly detect dangerous pathogens - saving food and saving lives.
- Hewatele — Hewatele is a social enterprise that provides affordable quality medical oxygen to all needy patients together with its affiliates CPHD and Mediquip Global.
- Nivi — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
Privately Held Companies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Australia
Investor stats
- Total investments: 105
- Lead/follow: no public data
Portfolio highlights
- OutcomesAI — OutcomesAI operates as a healthcare company, that combines AI Voice Agents with licensed nurses to deliver safe, scalable care across health systems.
- Apreo Health — Apreo Health is developer of medical apparatus designed for diagnosing or treating respiratory, pulmonary, and lung conditions.
- ABK Biomedical — At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors
We are a community focused fund and syndicate investing in frontier mental health: psychedelics, neurotech, precision psychiatry, digital therapeutics, holistic medicine, metabolic psychiatry, digital health, and artificial intelligence.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 24
- Lead/follow: no public data
Portfolio highlights
- Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
- Sanmai — Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders
- Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 189
- Lead/follow: no public data
Portfolio highlights
- Biomonde — Back to basics with a modern twist. Live larvae can be used to clean non-healing or infected wounds in a gentle, non-invasive sealed bag.
- Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
- ADC Biotechnology — Temukan prediksi Macau 4D 5D akurat di situs kami! Dapatkan bocoran togel toto Prediksi Macau Hari ini, dirumuskan oleh master prediktor. Bandingkan analisa Anda dan manfaatkan prediksi kami untuk meningkatkan peluang kemenangan Anda. Bergabunglah dengan kami untuk meraih JP impian. Salam JP
The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.
Show more...Investment focus
- Industry: Sensor, Medical, Wearables
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Seed, Series A
- Geography: United States, Colombia, India
Investor stats
- Total investments: 85
- Lead/follow: no public data
Portfolio highlights
- Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
- MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
- Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.
Show more...Investment focus
- Industry: Software, Energy, Solar
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Australia, United Kingdom
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- Tyba — Tyba's unified project simulation and operating platform helps teams develop, operate, and optimize standalone and hybrid storage projects.
- Heron Power — Heron Power is an energy technology startup focused on developing power electronics for the modern electrical grid. They aim to facilitate the expansion of electricity generation by innovating foundational technologies.
- Presto — Presto is a software platform to power magical charging experiences for fleets, mobility providers, and businesses.We believe that access to reliable and affordable charging is the key to unlocking mass electrification and fighting climate change.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Oceania Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!